Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19464887rdf:typepubmed:Citationlld:pubmed
pubmed-article:19464887lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:19464887lifeskim:mentionsumls-concept:C1513095lld:lifeskim
pubmed-article:19464887lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:19464887lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:19464887pubmed:issue13lld:pubmed
pubmed-article:19464887pubmed:dateCreated2009-6-9lld:pubmed
pubmed-article:19464887pubmed:abstractTextThe synthesis of a novel series of aminoquinoline derivatives 1a-p and their antiproliferative activities against A375 human melanoma cell line were described. Most compounds showed superior antiproliferative activities to Sorafenib as a reference compound. Among them, quinolinyloxymethylphenyl compounds 1k and 1l exhibited potent activities (IC(50)=0.77 and 0.79microM, respectively) and excellent selectivity against melanoma and fibroblast cell lines.lld:pubmed
pubmed-article:19464887pubmed:languageenglld:pubmed
pubmed-article:19464887pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19464887pubmed:citationSubsetIMlld:pubmed
pubmed-article:19464887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19464887pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19464887pubmed:statusMEDLINElld:pubmed
pubmed-article:19464887pubmed:monthJullld:pubmed
pubmed-article:19464887pubmed:issn1464-3405lld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:ChoiJung...lld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:OhChang-HyunC...lld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:KimDong JinDJlld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:ChoSeung...lld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:SimTae BoTBlld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:YooKyung HoKHlld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:HahJung-MiJMlld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:KimHwanHlld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:LeeSo HaSHlld:pubmed
pubmed-article:19464887pubmed:authorpubmed-author:NamBong SooBSlld:pubmed
pubmed-article:19464887pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19464887pubmed:day1lld:pubmed
pubmed-article:19464887pubmed:volume19lld:pubmed
pubmed-article:19464887pubmed:ownerNLMlld:pubmed
pubmed-article:19464887pubmed:authorsCompleteYlld:pubmed
pubmed-article:19464887pubmed:pagination3517-20lld:pubmed
pubmed-article:19464887pubmed:meshHeadingpubmed-meshheading:19464887...lld:pubmed
pubmed-article:19464887pubmed:meshHeadingpubmed-meshheading:19464887...lld:pubmed
pubmed-article:19464887pubmed:meshHeadingpubmed-meshheading:19464887...lld:pubmed
pubmed-article:19464887pubmed:meshHeadingpubmed-meshheading:19464887...lld:pubmed
pubmed-article:19464887pubmed:meshHeadingpubmed-meshheading:19464887...lld:pubmed
pubmed-article:19464887pubmed:meshHeadingpubmed-meshheading:19464887...lld:pubmed
pubmed-article:19464887pubmed:year2009lld:pubmed
pubmed-article:19464887pubmed:articleTitleAminoquinoline derivatives with antiproliferative activity against melanoma cell line.lld:pubmed
pubmed-article:19464887pubmed:affiliationLife Sciences Research Division, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 130-650, Republic of Korea.lld:pubmed
pubmed-article:19464887pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19464887pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:19464887lld:chembl